Helixmith Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Helixmith Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Helixmith's Price has increased by 100.00%, going from ₩0.00 to ₩0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach ₩0.00 – an increase of 100.00%. The Helixmith forecast is for Fair Value to reach ₩0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A207940 Stock Forecast | Samsung Biologics | Buy |
7
|
₩781.00k | Buy/Sell | ₩0.00B | 34.44% |
| A068270 Stock Forecast | Celltrion | Outperform |
16
|
₩189.00k | Buy/Sell | ₩215.28k | 21.69% |
| A091990 Stock Forecast | Celltrion Healthcare | - |
12
|
₩75.90k | Buy/Sell | ₩90.17k | -100.00% |
| A196170 Stock Forecast | ALTEOGEN | Outperform |
6
|
₩176.90k | Buy/Sell | ₩83.33k | -20.86% |
| A068760 Stock Forecast | Celltrion Pharm | - |
11
|
₩96.10k | Buy/Sell | ₩11.33k | -100.00% |
Helixmith Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Helixmith's Revenue has decreased by 34.10%, from ₩4.25B to ₩2.80B. In the next year, analysts are expecting an increase in Revenue, predicting it will reach ₩3.26B – an increase of 16.29%. The Helixmith forecast is for Revenue to reach ₩3.27B or grow by 16.84%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A141080 Stock Forecast | LegoChem Biosciences | Outperform |
7
|
₩68.10k | Buy/Sell | ₩66.50k | 35.10% |
| A006280 Stock Forecast | GC Biopharma | Buy |
16
|
₩114.30k | Buy/Sell | ₩146.43k | 25.98% |
| A214450 Stock Forecast | PharmaResearch | Outperform |
16
|
₩127.60k | Buy/Sell | ₩165.00k | 37.15% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A298380 Stock Forecast | ABL Bio | Outperform |
6
|
₩26.00k | Buy/Sell | ₩37.00k | 42.31% |
| A007390 Stock Forecast | NatureCell | - |
0
|
₩7.29k | Buy/Sell | ₩0.00 | -100.00% |
| A256840 Stock Forecast | BNC Korea | - |
0
|
₩3.56k | Buy/Sell | ₩0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A214370 Stock Forecast | Caregen | - |
18
|
₩22.00k | Buy/Sell | ₩50.00k | -100.00% |
| A086900 Stock Forecast | Medy-Tox | Outperform |
8
|
₩135.00k | Buy/Sell | ₩335.00k | 174.07% |
| A115450 Stock Forecast | HLB Therapeutics | - |
6
|
₩11.23k | Buy/Sell | ₩20.77k | -100.00% |
Helixmith EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Helixmith's EBITDA has seen a drop from ₩-42.99B to ₩-42.13B – a 1.99% decrease. According to 0 major analysts, Helixmith's EBITDA will fall by 1.40% in the next year, reaching ₩-41.54B. Professionals believe that By 2030, Helixmith's EBITDA will fall to ₩-41.52B– a 1.47% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A293780 Stock Forecast | AptaBio Therapeutics |
0
|
₩7.62k | Buy/Sell | ₩0.00 | -100.00% | |
| A182400 Stock Forecast | NKMAX CO. | - |
7
|
₩5.66k | Buy/Sell | ₩0.00 | -100.00% |
| A041960 Stock Forecast | Komipharm International | - |
6
|
₩4.39k | Buy/Sell | ₩0.00 | -100.00% |
Helixmith EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Helixmith's EBIT has gone down from ₩-55.08B to ₩-52.58B – a 4.54% drop. In the next year, 0 analysts estimate that Helixmith's EBIT will decrease by 0.64%, reaching ₩-52.24B. According to professional forecasts, in 2030, Helixmith's EBIT will decrease by 0.75%, reaching ₩-52.19B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A087010 Stock Forecast | Peptron | - |
6
|
₩29.00k | Buy/Sell | ₩35.00k | -100.00% |
| A065660 Stock Forecast | Anterogen.Co.,Ltd. | - |
7
|
₩14.01k | Buy/Sell | ₩0.00 | -100.00% |
| A144510 Stock Forecast | GC Cell | - |
11
|
₩38.50k | Buy/Sell | ₩74.00k | -100.00% |
Helixmith EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Helixmith's EPS has increased by 100.00%, going from ₩-2812.73 to ₩0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach ₩0.00 – an increase of 100.00%. The Helixmith forecast is for EPS to reach ₩0.00 or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A199800 Stock Forecast | ToolGen | - |
0
|
₩68.20k | Buy/Sell | ₩270.00k | -100.00% |
| A031390 Stock Forecast | Green Cross Cell | - |
14
|
₩38.55k | Buy/Sell | ₩80.00k | -100.00% |
| A299660 Stock Forecast | Cellid, | - |
5
|
₩4.27k | Buy/Sell | ₩0.00 | -100.00% |
.jpg)